- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Anthracycline‑Induced Cardiac Toxicity: A Clinical Review ; volume:40 ; number:04 ; year:2019 ; pages:465-475
Indian journal of medical & paediatric oncology ; 40, Heft 04 (2019), 465-475
- Contributor
-
Abbas, Adil Abdelhameed
AlAzmi, Aeshah Abdu Mubarak
- DOI
-
10.4103/ijmpo.ijmpo_106_19
- URN
-
urn:nbn:de:101:1-2021081213145315417806
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abbas, Adil Abdelhameed
- AlAzmi, Aeshah Abdu Mubarak
Other Objects (12)
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study
Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?
Anthracycline-induced cytotoxicity in the GL261 glioma model system
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study
Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?
Anthracycline-induced cytotoxicity in the GL261 glioma model system
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study
Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?
Anthracycline-induced cytotoxicity in the GL261 glioma model system
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity